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Introduction 
Many factors influence women’s experience of childbirth, including her response to pain in labour. 
While most women receive analgesia for labour, the pain experienced by each woman is highly 
variable (Jones et al., 2012). This unique experience is believed to be affected by not only 
physiological factors, such as maternal position in labour and mobility, but also psychosocial factors, 
including levels of fear, anxiety or confidence (Othman et al., 2012). A systematic review undertaken 
to examine which method of pain relief was most efficacious to women in childbirth concluded 
suitability of pain relief methods needed to be tailored to each woman’s circumstance, experience and 
expectation of labour pain (Jones et al., 2012). 
In recent years there has been a change in attitude towards labour analgesia. More women are 
accessing epidural analgesia, whereas, intrapartum opioids such as pethidine are less frequently used 
(Lindholm & Hildingsson, 2015). Studies that have examined women’s preferences for pain relief 
during the antenatal period identified women rated pethidine the least preferred pharmacological 
option due to the potential adverse effects (Henry & Nand, 2004: Madden et al., 2013). 
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While pethidine is still commonly used for pain management in childbirth, it is reported to produce 
maternal and neonatal adverse effects. These effects include sedation (Fairlie et al., 1999), vomiting 
(Ullman et al., 2010), prolonged labour (Khooshideh & Shahriari, 2009), reduced variability of fetal 
heart rate (Sekhavat & Behdad 2009; Solt et al., 2002), higher incidence of neonatal acidosis (Sosa et 
al., 2006), reduced Apgar scores (Sharma et al., 2004) and feeding difficulties for up to 6 weeks 
postpartum (Belsey et al., 1981; Burchell et al., 2016). Furthermore, the Australian and New Zealand 
College of Anaesthetists has recommended that pethidine use be discouraged in favour of other 
opioids due to the risk of toxicity from the accumulation of the metabolite norpethidine and associated 
neuroexcitatory effects that include nervousness, tremors, twitches, multifocal myoclonus and 
seizures (Schug et al., 2015). 
Despite these adverse effects, there are few alternative parenterally administered opioids used for 
labour pain, with choice limited to what is held at the different hospitals (Lindholm & Hildingsson, 
2015). Several recent studies have suggested fentanyl administered by the intranasal (IN) and the 
subcutaneous (SC) routes is effective for intrapartum analgesia (Fleet et al., 2015; Kerr et al., 2015; 
Kokki et al., 2015). Advantages of fentanyl include rapid onset of pain relief and no active metabolite 
to prolong adverse effects (Anderson, 2011). Advances in pain management in other settings have led 
to the use of these less-invasive techniques of administering fentanyl (Grape et al., 2010; Prommer & 
Thompson 2011). 
While women report increased satisfaction with the use of opioids compared to non-opioids to control 
labour pain (Othman et al., 2012), practitioners in the obstetric setting continue to debate which 
opioid and mode of administration provides the most effective pain relief (Ullman et al., 2010). A 
RCT was undertaken to compare the efficacy of fentanyl administered via different routes, with the 
standard practice of intramuscular (IM) pethidine use for women in labour. A secondary outcome for 
this study was to examine women’s breastfeeding experiences and satisfaction with the opiate 
received. Therefore, this study is the first to describe the experience of women administered fentanyl 
either intranasally (IN) or subcutaneously (SC) for labour analgesia and to compare these experiences 
to women who had received IM pethidine. 
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Participants 
Women were eligible to participate if they requested analgesia in labour, had no known medical 
conditions, an uncomplicated singleton pregnancy in a vertex presentation and were planning a 
vaginal birth at term (between 37 to 42 weeks gestation). Women were excluded if they had received 
pethidine or fentanyl within 24 hours prior to the establishment of active labour (regular contractions 
and a cervical dilatation of at least 3cm) or had a preference for an epidural.  
Ethics 
Ethics approval was granted by the Children’s Youth Women’s Health Service Human Research 
Committee on 27 October 2010 and the Southern Adelaide Clinical Human Research Ethics 
Committee on 14 December 2010 (ethics application number 380.09 and approval number 
REC2284/9/13). Recruitment occurred from January 2011 to April 2013. Women provided written 
informed consent in the antenatal period prior to randomisation. Verbal consent was then reconfirmed 
at time of interview 6 weeks post birth. 
Methods 
This study represents the third phase of a multi-centred, 3-arm parallel group, non-blinded randomised 
controlled trial (see detailed methods described in Fleet et al., 2015) that involved a follow up phone 
questionnaire at 6-weeks postpartum. Women were contacted by telephone by the primary researcher, 
who had not been involved in the women’s care, to participate in a questionnaire that focused on 
breastfeeding experience (see Fleet et al 2017), and satisfaction with treatment received. This paper 
reports the results of the two questions that related to satisfaction with treatment received. Each 
woman who received treatment, regardless of allocation, was asked whether she would use that form 
of drug again in a subsequent labour. The question was posed as a dichotomous (yes/no) response. For 
women who did not elaborate on this question the following prompt was used “Would you like to 
comment further on your experience of the treatment used?” A summative approach to content 
analysis was undertaken where comments were transcribed verbatim and coded in a table to identify 
categories (categorisation) and recurrent words and concepts were grouped (Hsieh & Shannon, 2005). 
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The occurrence (frequency) of each sub-category was recorded. Categories and sub-categories were 
confirmed by the co-authors, who also were not involved in data collection while women were in 
labour. 
Findings  
In total, 112 women provided descriptions of their experience for treatment received. Of whom 41 
women received IN fentanyl, 37 women received SC fentanyl, and 38 women received IM pethidine. 
This includes four women who were randomised to IN fentanyl, but who also received IM pethidine 
over the course of their labour (due to either a breach in protocol or as rescue analgesia post-
treatment). . 
Maternal characteristics and mode of birth were comparable between groups (see Fleet et al 2017, 
Tables 1 & 2), with the majority of women being primigravida and experiencing a spontaneous 
vaginal birth. However, significantly more women in the SC and IN fentanyl groups indicated that 
they would use the treatment again when compared to women who received pethidine (82.9% IN 
fentanyl, 80.6% SC fentanyl, 44.8% IM pethidine; p<0.01). When women’s experiences were 
analysed; three categories emerged—physical, cognitive and emotional effects. These three categories 
were then classified into sub-categories relating to positive and negative experiences (Table 1). 
Extracts are included to demonstrate the variations in statements. In addition, examples are provided 
for statements from women who received both IN fentanyl and IM pethidine.  
The majority of statements made by women in the fentanyl groups (87.8% IN fentanyl; 91.9% SC 
fentanyl) identified at least one of the positive sub-categories for physical, cognitive and emotional 
effects compared to 50% in the IM pethidine group. Further, 22.0% of women in the IN fentanyl 
group and 19.0% in the SC fentanyl group reported all three positive categories compared to one 
woman in the pethidine group. Whereas, the majority of women (89.7%) administered IM pethidine 
reported at least one negative effect when describing their experience. Even when positive and 
negative sub-categories were identified, the description of effects differed depending on which 
treatment and route was administered (Table 1). For example, women who self-administered 
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intranasal fentanyl reported strong positive emotional responses that demonstrated an increased 
enjoyment of the experience. While also acknowledging positive physical and cognitive effects. 
“Intranasal fentanyl – loved it. I was really happy with it, would recommend it to everyone. I 
will want to use again and would choose a hospital based on its availability. I found it really 
helped reduce the pain, felt in control, think it’s brilliant. Didn’t need to use anything else 
(P.74).” 
 “I’m really happy with the intranasal, it made contractions feel shorter, still had a peak but 
better break between contractions but still laboured quickly. Less intense, felt able to cope 
better (P.51).” 
Whereas women who had been administered SC fentanyl were more likely to focus on positive 
physical effects. 
“I really felt the subcutaneous fentanyl helped give me a sense of calm and relaxation 
between contractions even very close to birthing. Allowed me to focus better and it 
[subcutaneous fentanyl] helped reduce the intensity of the contraction better than the gas 
[nitrous oxide and oxygen] (P.138).” 
“Subcut[aneous] fentanyl definitely took away the pain a lot more than the gas [nitrous oxide 
and oxygen] did, so found it really helpful. Didn’t get any side effects. Found it really helped 
get me through the labour, I liked the gas at the start, but it wasn’t strong enough. The 
subcut[aneous] fentanyl reduced the intensity of the contractions (P.88).” 
Responses elicited from women who received IM pethidine were less descriptive and predominately 
focused on negative physical effects, even when a positive effect such as pain relief was achieved. 
The following statements demonstrate the variation in description of treatment effects, despite the 
identification of the same categories. 




“The pethidine make me very groggy and slowed labour, then it was hard to push but I did 
need something. Had the gas on strongest, and it wasn’t enough at that stage. So it did give 
some relief (P.132).” 
 Route of administration also was a focus of a number of responses. For example, women who self-
administered intranasal fentanyl were more likely to report a positive experience and an increased 
sense of control. 
“…. It was great I could self-administer [the intranasal fentanyl], very happy with the effect. 
Able to time doses well to give maximum benefit. I noticed the difference when I tried not to 
use it (P.69).” 
“Good pain relief and it [intranasal fentanyl] enabled me to walk around and remain alert. It 
really worked, I was able to get up and walk around. It was great (P.40).” 
In comparison, when women were administered SC fentanyl or IM pethidine they needed to wait a 
specified time due to the longer half-life of the drug and relied on staff to administer the dose.  
“The initial [fentanyl 200mcg] dose was very effective.  Subsequent [50mcg] dose wore off 
too quickly. I became anxious waiting for the next dose, would prefer to use intranasal 
fentanyl next time so could self-administer more frequently (P.2).” 
 “Really happy with effect from subcut [subcutaneous] fentanyl. Difficult with OP position. 
Subcut got me through to 9cm…. Smaller doses of [SC] fentanyl didn’t give as much pain 
relief as first dose which was really effective (P.121).” 
“I wouldn’t use [pethidine] again as it only gave a short term effect. It [pethidine] helped a 
little but I still felt the pain too much. Only worked for a very short time, less than half an 
hour (P.117). 
“I believe pethidine did help a bit with the pain but then it wore off after a short amount of 




Interestingly, when women discussed their experience pain was not always the focus and even on 
occasions when pain relief was not achieved women still reported beneficial cognitive and emotional 
experiences.  
“I only used the intranasal fentanyl, found it really helpful and would definitely use it again. 
Intranasal fentanyl really helped me get through. Before it I didn’t think I could continue. 
Definitely gave a better break and reduced the intensity. Very happy with effect (P.104).” 
“Couldn’t feel a change in the intensity of the pain [from IN fentanyl] but did feel I was able 
to focus better and cope with the contractions. I was much more relaxed when using the 
intranasal fentanyl despite still experiencing strong pain (P.61).” 
“I was more calm with the [subcutaneous] fentanyl. Liked that I could have it (fentanyl) more 
frequently when needed. Didn’t notice a real difference in pain but did cope better with it 
(pain) (P.54).”  
“[The SC fentanyl] helped relax me. Would definitely use again, felt it helped me cope. For 
my previous birth I used an epidural, so happy I was able to do without it (P.110).” 
“With pethidine I was more relaxed between contractions, though it [pethidine] was not very 
effective for pain. I would consider using pethidine again in the same circumstances. Happy 
with outcome overall, feel it was a good experience (P.63).” 
“I’m happy with the effect from pethidine as I don’t feel it [pethidine] had any side effects. 
Seemed to give a little help (P.123).” 
Few women in the fentanyl groups reported a negative effect, but of those who did, negativity was 
related to not achieving the expected pain relief rather than any adverse effects. For example  
“Was difficult to determine real benefit [of intranasal fentanyl] due to rapid birth (P.23).”  
“I didn’t feel the intranasal helped (P.28).” 
“Really difficult to tell if it [SC fentanyl] helped as baby born within 20 mins of dose (P.43).” 
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“Don’t feel it [SC fentanyl] really helped with the pain, happy though there were no side 
effects. Had used pethidine in a previous birth and wouldn’t want to use pethidine again 
because of the side effects (P.136).” 
In comparison, negative experiences were commonly reported by women in the IM pethidine group 
and were commonly related to negative physical effects. 
“The pethidine knocked me out. It [IM pethidine] didn’t help with the pain. Made me sleep 
between contractions but wasn’t a good experience (P.8).”  
“Felt really out of it even after the birth. Don’t recall that it gave a reduction in pain. Felt 
distant and dissociated with birth. Don’t even remember the early period after birth, looked 
at photos and didn’t remember it happening. Disappointed with effect (P.137).” 
Of the four women who received both IN fentanyl and IM pethidine, all four women commented that 
IN fentanyl provided more pain relief than IM pethidine. For example, Participant 7 requested 
alternative analgesia after 2 hours of IN fentanyl use and was administered IM pethidine. Both 
negative physical and cognitive experiences were reported with the use of IM pethidine, whereas 
positive emotional experience was identified from the description of the IN fentanyl use. 
“Pethidine slowed everything down, I really didn’t like the experience – I felt really out of it. 
At the time I wasn’t sure if the intranasal fentanyl was still helping but after using the 
pethidine I was more aware that it had been, without causing the high or sedation (P.7).” 
Participant 44 had been administered pethidine overnight when labour established and then 
randomised 7.4 hours later to receive IN fentanyl, an hour before she gave birth. Both positive 
emotional and cognitive descriptions were reported with the use of IN fentanyl. This contrasts to the 
negative cognitive and physical experience reported about the use of IM pethidine. 
“I really liked the intranasal (fentanyl) spray I felt able to cope and focus, it allowed me to 
push as I had been overwhelmed with the whole induction and frequency of contractions and 
couldn’t do anything due to constant pain, there was no break between contractions. 
Pethidine though made me feel out of it. I kept falling asleep and not remembering what I was 
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doing. The gas was also horrible it made me feel out of control. I couldn’t have done it 
without the intranasal fentanyl (P.44).” 
Discussion  
When the comments were grouped into categories and sub-categories, the positive sub-categories 
were seen most often in women from the fentanyl groups. The positive emotional sub-category was 
identified with greater frequency among women in the IN fentanyl group, compared to women in 
either the SC fentanyl or IM pethidine groups. Both fentanyl groups had only low frequencies of 
negative sub-categories. In contrast, women in the IM pethidine group had greater frequency of all 
three negative sub-categories, with negative physical effects being identified most often (Table 1). 
Women in the IM pethidine group most often reported negative physical effects from treatment and 
equivocal positive and negative emotional experiences. Only one other study was identified that 
specifically explored women’s experiences of opioid analgesia use during labour (Jantjes et al., 2007), 
and identified findings similar to this study. Jantjes et al. (2007) examined the emotional experiences 
of primipara women who used pethidine combined with an antihistamine, hydroxyzine, during labour. 
Their findings suggest that women’s experiences from using pethidine varied significantly from 
expressions of joy and happiness to anxiety, anger and despondence (Jantjes et al., 2007), further 
highlighting the potential for pethidine use to provoke contrasting emotional responses. 
Satisfaction with the drug, and hence intention to use the treatment again, may also have been 
influenced by the reduced prevalence of adverse effects and the ability to mobilise (Ross, 1998). In 
this study, participants in the fentanyl groups reported fewer adverse effects than those in the 
pethidine group. In addition, women in the fentanyl groups reported the ability to mobilise, possibly 
due to less sedation. This mobility may have allowed them to adopt a variety of positions to help ease 
painful contractions. In contrast, women who received IM pethidine reported adverse effects such as 
nausea, sedation and feeling dissociated which may have reduced their ability to ambulate. 
The technique and timing of administration is another aspect that requires further investigation and 
may have contributed to the woman’s overall experience. While it was not considered ethical to blind 
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this study as it would entail participants receiving all three routes of administration, preference for the 
route received may have affected the woman’s perception of autonomy (McNicol et al., 2015). This 
may in part also explain the positive comments made by women in relation to IN fentanyl, which was 
administered using a patient controlled intranasal applicator device. Patient controlled analgesia has 
been shown to produce greater satisfaction and analgesic effect in women (Schug et al 2015). In 
addition, route of administration may be affected by a placebo effect (Hui et al., 2014). For example, a 
placebo effect could be influenced by the participants’ expectations that a treatment would provide 
benefit and/or by the practitioners’ expressed attitudes towards the treatment provided (Porto, 2011). 
Further research should consider participants’ expectations prior to treatment, as well as how 
practitioners’ involvement in care may influence these expectations. This is particularly important as 
models of care, such as continuity of carer has been associated to improve maternal satisfaction, 
reduce anxiety and the need for pharmacological forms of pain relief (Leap et al 2012).  
Conclusion  
In this study self-administration of intranasal fentanyl in labour resulted in positive emotional 
experiences with women often commenting on their sense of control and autonomy. Whereas, women 
who were administered SC fentanyl were more likely to describe the positive physical effects of the 
treatment. Fentanyl administered by the IN or SC routes offers women additional choices for pain 
relief in labour that are less invasive than traditional methods. Route of administration should be 
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Table 1 Women’s experience of treatment 
Category Sub-categories 












Positive: Excellent pain relief/ relieved pain/ 
more pain relief than gas/ enabled relaxation/ 
better break/ able to be mobile 
29.6 40.0 16.3 
Negative: Gave no relief/ didn’t help at all / 
wore off too quickly/ slowed everything 
down/ not strong enough/ felt sedated/ sick 
8.2 12.3 47.1 
Cognitive 
experience 
Positive: Felt alert/ better focused/ felt really 
connected/ gave a sense of calm / better able 
to cope/communicate/ felt more in control 
14.8 13.1 1.0 
Negative: felt out of it/ didn’t have a good 
experience/ not remembering/ distant/ 
disassociated 
0 0 10.6 
Emotional 
experience 
Positive: loved it/ perfect/ promoted it / 
amazing/ great/ really helped/ happy/ 
wonderful/ impressed/ enabled me/ didn’t 
need an epidural/ better than an epidural 
45.2 30.8 11.5 
Negative: lost confidence/ left feeling fearful 
/ anxious/ disappointed/ didn’t help/ didn’t 
like it / preference for gas or epidural 
2.2 3.8 13.5 


















 This study is the first study to describe the experience of women administered intranasal 
and subcutaneous fentanyl for labour analgesia. 
 Women who self-administered intranasal fentanyl reported positive emotional responses 
that demonstrated increased sense of autonomy and satisfaction, compared to women 
administered either subcutaneous fentanyl or intramuscular pethidine. 
 Responses from women who received pethidine predominately focused on negative effects, 
even when pain relief was achieved. 
 
 
